| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/05/2011 | US20110104304 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders |
| 05/05/2011 | US20110104293 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 05/05/2011 | US20110104263 Claudin-4 binding peptides, compositions and methods of use |
| 05/05/2011 | US20110104260 Vaccine against varicella zoster virus |
| 05/05/2011 | US20110104256 Methods for treating or preventing colorectal cancer |
| 05/05/2011 | US20110104252 Anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 05/05/2011 | US20110104249 Oncotherapeutic Application of Inhibitors of High-Affinity Glucose Transporters |
| 05/05/2011 | US20110104248 Liposomes and immunopotentiating compositions containing the same |
| 05/05/2011 | US20110104246 Method of wound treatment using liquid gallium nitrate |
| 05/05/2011 | US20110104236 Therapeutic compositions for treatment of ocular inflammatory disorders |
| 05/05/2011 | US20110104234 Biodegradable Modified Carpolactone Polymers for Fabrication and Coating Medical Devices |
| 05/05/2011 | US20110104228 Self-eliminating coatings |
| 05/05/2011 | US20110104227 Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants |
| 05/05/2011 | US20110104226 Peptides having binding affinity to an antibody which recognizes an epitope on an a1 loop 2 or beta2 loop 1 of an adrenoreceptor |
| 05/05/2011 | US20110104216 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product |
| 05/05/2011 | US20110104211 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/05/2011 | US20110104210 Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors |
| 05/05/2011 | US20110104209 Dna sequence, and recombinant preparation of the grass pollen allergen lol p4 |
| 05/05/2011 | US20110104208 Enzyme Treatment of Glucans |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104206 Methods and compositions for sustained delivery of drugs |
| 05/05/2011 | US20110104205 Heterologous protection against pasteurella multocida provided by p. multocida fur cells and the outer-membrane protein extracts thereof |
| 05/05/2011 | US20110104204 Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
| 05/05/2011 | US20110104203 virus-like platform for rapid vaccine discovery |
| 05/05/2011 | US20110104202 Modified Influenza Virus For Monitoring And Improving Vaccine Efficiency |
| 05/05/2011 | US20110104201 Porcine Reproductive and Respiratory Syndrome Vaccine Based on Isolate JA-142 |
| 05/05/2011 | US20110104200 Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines |
| 05/05/2011 | US20110104199 MVA Expressing Modified HIV Envelope, GAG, and POL Genes |
| 05/05/2011 | US20110104198 Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same |
| 05/05/2011 | US20110104196 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 05/05/2011 | US20110104195 Plasmodium falciparum sporozoite and liver stage antigens |
| 05/05/2011 | US20110104194 Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization |
| 05/05/2011 | US20110104193 Combination neisserial compositions |
| 05/05/2011 | US20110104192 Norovirus and sapovirus antigens |
| 05/05/2011 | US20110104191 Malva mosaic virus and virus-like particles and uses thereof |
| 05/05/2011 | US20110104190 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 05/05/2011 | US20110104189 Compositions obtained from chlorella extract having immunomodulating properties |
| 05/05/2011 | US20110104186 Small molecule immunopotentiators and assays for their detection |
| 05/05/2011 | US20110104185 Antibody fragment-polymer conjugates and uses of same |
| 05/05/2011 | US20110104184 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 05/05/2011 | US20110104183 Use of sip1 as determinant of breast cancer stemness |
| 05/05/2011 | US20110104182 Cd40 antibody formulation and methods |
| 05/05/2011 | US20110104181 Modulation of synaptogenesis |
| 05/05/2011 | US20110104180 New vaccine for the treatment of mycobacterium related disorders |
| 05/05/2011 | US20110104179 Protease inhibitory peptides |
| 05/05/2011 | US20110104178 Novel avian astrovirus |
| 05/05/2011 | US20110104177 Histone deacetylase inhibitors, combination therapies and methods of use |
| 05/05/2011 | US20110104176 Antibody specifically binding to c-met and use thereof |
| 05/05/2011 | US20110104175 Methods of treatment for pulmonary fibrosis |
| 05/05/2011 | US20110104174 Antibodies to receptor for advanced glycation end products (rage) and uses thereof |
| 05/05/2011 | US20110104173 Inhibition of degradation of extracellular matrix |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104171 EphA4 Polypeptide Having a Novel Activity and Use Thereof |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104168 Detoxified pneumococcal neuraminidase and uses thereof |
| 05/05/2011 | US20110104167 Compositions and Methods for Diagnosing and Treating Insulin Resistance |
| 05/05/2011 | US20110104166 Methods and Compositions for Treating Polyps |
| 05/05/2011 | US20110104165 Method of upregulating sorla for the treatment of alzheimer's disease |
| 05/05/2011 | US20110104164 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 05/05/2011 | US20110104163 Anti-hiv domain antibodies and method of making and using same |
| 05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
| 05/05/2011 | US20110104161 Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer |
| 05/05/2011 | US20110104160 Medicament for treating cancer |
| 05/05/2011 | US20110104159 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 05/05/2011 | US20110104158 Deuterium bearing analogs of anastrozole as aromatase inhibitors for the treatment of breast cancer |
| 05/05/2011 | US20110104157 Liver cancer drug |
| 05/05/2011 | US20110104156 Methods and materials for treating autoimmune and/or complement mediated diseases and conditions |
| 05/05/2011 | US20110104155 Drug delivery to the anterior and posterior segments of the eye using eye drops |
| 05/05/2011 | US20110104154 Single nucleotide polymorphisms and genes associated with age-related macular degeneration |
| 05/05/2011 | US20110104153 Use of immunoregulatory nk cell populations for predicting the efficacy of anti-il-2r antibodies in multiple sclerosis patients |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104151 Microparticle compositions and methods for treating age-related macular degeneration |
| 05/05/2011 | US20110104150 Anti-cd19 antibodies and uses in b cell disorders |
| 05/05/2011 | US20110104149 SingleC-9 Binding Agents |
| 05/05/2011 | US20110104148 Antibodies to Carcinoembryonic Antigen (CEA), Methods of Making Same, and Uses Thereof |
| 05/05/2011 | US20110104147 Identification of Tumor-Associated Markers for Diagnosis and Therapy |
| 05/05/2011 | US20110104146 Antithrombotic agents and methods of use thereof |
| 05/05/2011 | US20110104145 Method for the treatment or prophylaxis of chronic inflammatory diseases |
| 05/05/2011 | US20110104144 Methods for treating cutaneous lupus using aminoisoindoline compounds |
| 05/05/2011 | US20110104143 Treating Basal-Like Genotype Cancers |
| 05/05/2011 | US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds |
| 05/05/2011 | US20110104113 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device |
| 05/05/2011 | US20110104110 Substituted indole derivatives and methods of use thereof |
| 05/05/2011 | US20110104109 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 05/05/2011 | US20110104108 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
| 05/05/2011 | US20110104105 Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same |
| 05/05/2011 | US20110104104 Blockage of interferon-gamma for prevention of polymicrobial synergy |
| 05/05/2011 | US20110104103 Method of conjugating therapeutic compounds to cell targeting devices via metal complexes |
| 05/05/2011 | US20110104101 Immunotherapy for Unresectable Pancreatic Cancer |
| 05/05/2011 | US20110104069 Multi-functional biodegradable particles for selectable targeting, imaging, and therapeutic delivery and use thereof for treating ocular disorders |
| 05/05/2011 | US20110104064 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals |
| 05/05/2011 | US20110104061 Treatment of renal hypertension or carotid sinus syndrome with adventitial pharmaceutical sympathetic denervation or neuromodulation |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | US20110104058 Dimeric molecular complexes |
| 05/05/2011 | US20110104052 Methods of synthesis and use of chemospheres |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | US20110100030 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product |
| 05/05/2011 | CA2779816A1 Modified meningococcal fhbp polypeptides |
| 05/05/2011 | CA2779613A1 Apparatus and method for cryogranulating a pharmaceutical composition |